About ATAVISTIK BIO, INC.
Atavistik Bio is a clinical-stage biotechnology company focused on developing novel allosteric therapeutics for the treatment of serious diseases, particularly in the field of rare hematology.
Development of novel allosteric therapeuticsSelective modulation of disease-causing proteinsAdvancement of multiple programs with best-in-class potentialInternal discovery platform for identifying functional pockets across protein classes
Is this your company?
Claim ATAVISTIK BIO, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim ATAVISTIK BIO, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.